Concepedia
Statistics
Publications
4
Citations
169
H-Index
Active since
2019
Affiliations
Oncode Institute(Current)
The Netherlands Cancer Institute
Elselien Frijlink is an author at Oncode Institute specializing in oncology, cancer immunotherapy, and immunology.
Publications per year
2019–2024
Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8+ T cells
Elisa Matas-Rico, Elselien Frijlink, Irene van der Haar Àvila et al. · Cell Reports · 2021 · 76 citations · Full text
Medicine, Immunology, Oncology +17
Radiotherapy and Cisplatin Increase Immunotherapy Efficacy by Enabling Local and Systemic Intratumoral T-cell Activity
Paula Kroon, Elselien Frijlink, Victoria Iglesias‐Guimarais et al. · Cancer Immunology Research · 2019 · 46 citations · Full text
PD-1 or CTLA-4 blockade promotes CD86-driven Treg responses upon radiotherapy of lymphocyte-depleted cancer in mice
Elselien Frijlink, Douwe M. T. Bosma, Julia Busselaar et al. · Journal of Clinical Investigation · 2024 · 30 citations · Full text
Life Sciences, Immunology, Oncology +17
Effects of valproic acid on histone deacetylase inhibition in vitro and in glioblastoma patient samples
Sharon Berendsen, Elselien Frijlink, Jérôme Kroonen et al. · Neuro-Oncology Advances · 2019 · 17 citations · Full text
Medicine, Oncology, Pharmacology +17
1–4 of 4